An exploratory cost-effectiveness analysis of a novel tissue valve compared with mechanical valves for surgical aortic valve replacement in subgroups of people aged 55-64 and 65+ with aortic stenosis in the UK
CONCLUSIONS: The exploratory analysis suggests that the novel tissue valve could be a cost-effective intervention for people over the age of 55 with AS who are suitable for SAVR in the UK.PMID:37638585 | DOI:10.1080/14737167.2023.2249611
Source: Expert Review of Pharmacoeconomics and Outcomes Research - Category: Health Management Authors: Robert Malcolm Ciara Buckley Judith Shore Angela Stainthorpe Belen Marti Andrea White Jens Deckert Matteo Vernia Jo ão L Carapinha Ana L ópez-Marco Nicolas Nikolaidis Olaf Wendler Source Type: research
More News: Aortic Stenosis | Cardiology | Health Management | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | UK Health